MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
MiNDERA Corporation has raised $25.4M in total funding. The most recent round was Convertible Note. The last funding was announced in July 2024.
MiNDERA Corporation's investors include Rockmont Investments, Mountain Group Capital, Scientific Health Development Partners, MedTech Innovator, Primer Capital.
MiNDERA Corporation is headquartered in South San Francisco, United States.
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
MiNDERA Corporation is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MiNDERA Corporation — Funding & Investors." VCBacked, July 31, 2024, https://www.vcbacked.co/company/mindera-corporation. Accessed November 13, 2026.
VCBacked. (2024). MiNDERA Corporation — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/mindera-corporation
{{cite web |title=MiNDERA Corporation — Funding & Investors |url=https://www.vcbacked.co/company/mindera-corporation |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at MiNDERA Corporation? Request a listing update